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The explosive growth of scientists, scientific journals, articles and findings in recent years ​1,2 
exponentially increases the difficulty scientists face in navigating prior knowledge and collectively 
reasoning over it to drive future advance ​3,4​. This challenge is exacerbated by uncertainty about the 
reproducibility of published findings ​5–8​. The availability of massive digital archives, machine 
reading and extraction tools on the one hand, and automated high-throughput experiments on the 
other, allow us to evaluate these challenges at scale and identify novel opportunities for accelerating 
scientific advance ​9​. Here we demonstrate a Bayesian calculus that enables the positive prediction of 
robust, replicable scientific claims with findings automatically extracted from published literature 
on gene interactions. We matched these findings, filtered by science, with unfiltered gene 
interactions measured by the massive LINCS L1000 high-throughput experiment to identify and 
counteract sources of bias. Our calculus is built on easily extracted publication meta-data regarding 
the position of a scientific claim within the web of prior knowledge, and its breadth of support 
across institutions, authors and communities, revealing that scientifically focused but socially and 
institutionally independent research activity is most likely to replicate. This contrasts with the 
ineffectiveness of alternative strategies like “follow the leader”—trusting top journals and top 
scientists—which do not predict robust findings. These findings recommend policies that go against 
the common practice of channeling biomedical research funding into centralized research consortia 
and institutes rather than dispersing it more broadly. Our results demonstrate that robust scientific 
findings hinge upon a delicate balance of shared focus and independence, and that this complex 
pattern can be computationally exploited to decode bias and predict the replicability of published 
findings. These insights provide guidance for scientists navigating the research literature and for 
science funders seeking to improve it. Moreover, our project models an entirely machine-driven 
research pipeline, from machine reading to evaluation, that could be incorporated by intelligent 
algorithms to augment scientific search, recommending fruitful research hypotheses to accelerate 
cumulative scientific advance. 
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Millions of research papers are published globally each year​3,4​, with nearly a million biomedical articles 
published and indexed in MEDLINE, and more than a hundred thousand that discuss genes and their 
biological interactions. Popular individual genetic pathways receive attention from thousands of papers. 
This deluge of information makes it very difficult for researchers and other audiences of science to decide 
what to trust—what insights will replicate and generalize beyond the particular experiment or observation 
from which they were initially demonstrated. More certainty about what findings to trust will allow us to 
better select useful signals from science that advance science and accelerate technology. Knowing what 
findings are robust will help scientists decide what to study next, policy-makers and philanthropists what 
to fund next, and institutes and technologists what next to develop as life-saving medical diagnostics and 
therapies. In this investigation, we ask how to predict certain signals from scientific publications. We 
further consider the implications of our predictions for how scientific institutions might be reformed to 
improve those signals. Subjective bias is an inevitable reality of published science. Accurate and robust 
insight about nature is only one of several factors scientists consider as they undertake research and 
publish findings. They must also strategically think about scientific influence and academic survival. 
What would be theoretically significant, what will attract attention and what can inspire scientists to build 
on their work in future? What will journal editors and reviewers allow​10​? What will patrons fund? What 
will promotion committees accept? Beyond complex motivations, scientists, their experiments and 
observations are situated in particular positions with respect to their objects of study, which defy detached 
and universal notions of objectivity​11​ and necessarily shape their assessments. Scientists foster 
expectations inculcated from disciplinary education and prior experience​12​, and they rationally incorporate 
the beliefs of those they trust—respected mentors and colleagues—into their own scientific expectations 
and certainties​6​. These contextual forces add noise to the signal about what findings will replicate and 
generalize, above and beyond the complexity involved in deciphering experimental and observational 
protocols from ambiguous language.  
 
Above the level of the scientist, the modern scientific system promulgates predictable bias. Competition 
between journals makes it far easier to publish positive findings than neutral or ‘negative’ ones​1,2​, which 
become underrepresented in the published record​5​. Moreover, favorable conditions for the “wisdom of 
crowds” phenomenon​13​, where collectives produce systematically more accurate estimates than 
individuals, are widely violated in science. Crowds are wise when their members have access to 
independent data​14​ or utilize independent methods​15​ to derive their answers, but they falter when engaged 
in centralized communication​16,17​ and share prior experience, knowledge, and methods​9​. By contrast, the 
modern life sciences are characterized by intensive and repeated collaboration​18–20​, increasingly large​21,22 
and distributed teams​23​, star scientists​24,25​, canonical citations​26,27​ and expensive shared equipment​18,20​. 
 
These forces have led to widespread concerns regarding the reliability and reproducibility of findings in 
fields ranging from pharmacology​7,28,29​ ​5​ and genetics​5,30–32​ 3,4​ to psychology​33,34​ with widespread 
implications for the accumulation of certainty in science. Some have even feared that distortions 
associated with publication and confirmation bias could lead to the canonization of false facts​10​. This is a 
problem for scientists, but also science as a system of insights on which future innovation relies. Prior 
work has attempted to identify the robust replicability of the scientific literature and identify sources of 
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 distortion that might weaken the signal of science through simulation​10,35,36​, experiments​33,37​, and 
meta-analysis of prior results​9,38​. Psychologists have called efforts to replicate the robust essence of an 
experiment with an alternative research design and methods a “conceptual replication” ​39​. Here we build 
on that work by demonstrating an automated research pipeline that (1) extracts gene-gene interaction 
claims from the biomedical literature, then (2) aligns them for conceptual replication with results from the 
massively replicated LINCS L1000 high-throughput experiment (Fig. 1), (3) identifies factors that 
increase and decrease the likelihood of replication and (4) updates our understanding and scientific 
certainty through a Bayesian calculus (Fig. 2). Finally, we use the results of our investigation (Fig. 3) to 
identify opportunities that could redesign scientific institutions and investigations for accelerated advance 
(Fig. 4). 
 
A number of scientific and social factors could influence the likelihood that a claim is robust and 
generalizes. Two important classes of factors involve (1) how a claim fits into prior knowledge about 
nature and (2) its breadth of prior support. We may investigate how a claim fits with preexisting 
knowledge by assessing its position in the complex network of other scientific claims. A claim may be 
central or peripheral in the network, and entire claim networks may be decentralized or hierarchical, 
controlled through a small number of central nodes like the CEO of a corporation. New scientific claims 
about the influence of central nodes, such as genes at the center of a genetic regulatory network, will be 
more plausible than claims about peripheral genes for which we have no prior signals of influence. A 
claim’s plausibility may also be affected by its position in the macro-structure of the network. If a claim 
about a genetic influence pathway is embedded within a large, dense cluster of claims about related 
interactions, the structure and direction of those interactions may logically and physically constrain the 
direction of the focal claim​6​, which might help researchers triangulate the correct, robust claim. The 
presence of other researchers asking nearby questions might also socially discipline researchers to share 
their most robust results, as their work will receive scrutiny by contemporaries.  
 
We may examine a scientific claim’s breadth of prior support through evaluating the range researchers 
who have reiterated it and the depth of time over which a claim has been examined. Nevertheless, recent 
research has shown that the independence underlying a claims’ support matters. More dependencies 
linking research that forwards a claim because they share authors, institutions, methods, or reference the 
same prior work decrease the replicability of that claim by outsiders ​9​. Dense communities become 
scientific echo-chambers that drive out diverse perspectives​40​, ignoring dissent or precisely reproducing 
fragile experiments unlikely to generalize beyond the context of initial demonstration. In biomedicine, 
findings from dense social and methodological communities are less likely to become relevant to human 
health and enter the clinic as practical diagnostics or therapies. They have not yet received independent 
support. By contrast, if more, independent research communities support a scientific claim, it will more 
likely be robust and generalize because it already has.  
 
Other features of apparent support also exist, most notably the authority of whether a finding was 
published in elite, high-impact journals, or was authored by scientists from elite, strong reputation 
schools. As our analysis below reveals, however, these status signals deceive and are not associated with 
robust replication. 
 
3
 Automated Validation Pipelines 
In order to predict robust signals from published science, we must first extract claims from published 
literature. Many prominent efforts have manually extracted statements regarding specific biological and 
chemical interactions from the literature and aggregate them into publicly available databases, which 
include the Gene Ontology​41​, Comparative Toxicogenomics Database​6​, the American Chemical Society’s 
CASREACT, and others. These projects take a crisp view of logical inference that does not directly 
account for history and uncertainty. In contrast, we deploy two algorithmic approaches built on distinct 
architectures, GeneWays​7​ and Literome​8​. The GeneWays system (portmanteau for genetics and pathways) 
semantically parses the biomedical literature. It first identifies biological substances and 
processes—nouns and verbs—then parses them with a context-free grammar tuned to the sublanguage of 
biomedicine​42​ that extracts direct and indirect relations yielding a graph with directed links from source to 
target. Proteins may bind, activate, inhibit, or unleash more specific properties (acetylate, methylate, 
phosphorylate) upon their targets​43​. We simplify these interactions into positive (e.g., ‘activate’, 
‘enhance’, ‘increase’, ‘promote’, ‘stimulate’, ‘[over]produce’, ‘upregulate’, etc.) and negative (e.g., 
‘inactivate’, ‘depress’, ‘limit’, ‘inhibit’, ‘constrain’, ‘hinder’, and ‘downregulate’, etc.) Literome inverts 
the GeneWays pipeline and begins by parsing articles into dependent clauses​44​, then extracts biological 
entities, including genes and proteins. From co-presence within parsed phrases, Literome identifies 
directed relationships and then filters these by their correspondence to existing gene relationships from 
the annotated GENIA dataset​45​. “Gene” in this context is used as a shorthand for “gene or gene product”, 
especially in reference to the action source, and henceforth we adopt this abbreviation. 
 
For both datasets, we limited examination of claims extracted from article abstracts to increase the 
likelihood that they were not merely reiterated, but empirically demonstrated in the associated article. The 
GeneWays and Literome approaches and associated gene-gene interaction datasets were derived from 
overlapping collections of gene-related articles present in MEDLINE (GeneWays 197K, Literome 220K). 
GeneWays and Literome precision is evaluated as 95% and 25%, their percentage of positive interactions 
96% and 77%, as shown in Fig. 1, panels a and b. In summary, GeneWays is more accurate, and Literome 
less constrained: GeneWays and Literome yield directed genetic graphs with ​5141 ​genes involved in 
23405 ​ interactions, ​10703​ genes engaged in ​144172 i​nteractions, respectively, yielding an overlap of ​4516 
genes, but only ​6516​ overlapping interactions. We perform all of our analyses on both, independently 
derived datasets.  
 
Next, we derive specific measures associated with how a claim fits into preexisting knowledge about 
genetic interactions and its breadth of support from article data and meta-data, as illustrated in Fig. 3 and 
detailed in the supplement. We measure each genetic regulatory interaction’s position within preexisting 
knowledge by (1) the centrality of its gene source and target, as well as (2) the partition size of which it is 
a member, derived from dense connection among all published genetic claims. We measure the breadth of 
each interaction’s support by the (1) the density of articles published on it each year, (2) number of years 
over which it has been investigated, (3) number of collaborative communities investigating it, (4) absolute 
size of the particular community engaged in making each interaction claim, and (5) size of that 
community relative to others that investigate it. We also derive measures capturing the reputation of the 
institution hosting the underlying research and the journal publishing the claim, and a number of related 
variables.  
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 We merged these findings with the massively high-throughput NIH Library of Integrated Network-Based 
Cellular Signatures (LINCS) L1000 experiment that perturbs 77 distinct cell lines with several different 
perturbation types, such as cDNA for overexpression of wild-type gene for 5.8K genes​46​. Gene 
overexpression is a technique that utilizes expression vectors to force high levels of a gene’s coding 
sequence. The resultant effect is high steady state mRNA levels and high steady state protein levels. This 
enables a vast gene-gene causal experiment: if one gene product is increased and it consistently leads to 
the increase or reduction in another gene across cell lines, perturbagens, dosage and time, which suggests 
that the over-expressed gene has a consistent and likely causal association with the other. We compute the 
mean z-score across experiments for genetic regulatory interactions and transform to (0,1) with the 
normal cumulative density function, denoting this the average experimental strength of the interaction.  
 
Bayesian Signals from Science 
We predict scientific certainty and the class of an interaction (neutral, positive or negative) through a 
Bayesian calculus built atop established statistical and machine learning methods that incorporate the 
features capturing position within pre-existing knowledge and depth of prior support described above. 
Some features occur at the level of the genetic regulatory interaction (e.g., position of source and target 
genes within the network of prior knowledge or the number of research communities publishing on the 
interaction). Others occur at the level of the published claim (e.g., size of the research community 
publishing a particular paper about the interaction). All of these features vary with time. We use these 
features to predict the robust, aggregate results of LINCS L1000 experiments pertaining to the same 
source and target gene across distinct trials, dosages, tissues and durations.  
 
Cross-tabulation between the value of published claims and the average LINCS L1000 experimental 
results highlights a contrast. Claims in the biomedical literature tend to be either positive or negative, with 
a strong positive bias. The distribution of experimental interactions does not share this bias, normally 
distributed and varying smoothly from negative to positive, peaked and centered at 0.5, indicating a 
“neutral”, inconsistent or nonexistent interaction between those genes. The contrast between published 
finding and experimental data suggests the extent of the file drawer problem in science where scientists 
euphemistically “file”, but do not publish negative or inconclusive results​47,48​. We note that the correlation 
between published and experimental results increases markedly as we consider more popular interactions 
(see Extended Data Fig. 1). These observations led us to partition experimental interactions into 3 
categories: neutral, positive and negative. First, we build models to predict the neutrality of an interaction 
(see SI). Second, we built models to predict whether positive and negative published claims correctly 
align with positive and negative experimental interactions. We separately built logistic regression and 
random forest models to estimate the influence of each feature on each outcome. Logistic regressions 
provide us with interpretable directional estimates, but assume conditional independence between 
features. Random forests provide us with better estimates of each feature’s importance, but reduce 
interpretability by allowing nonlinear feature interactions. The most important features regarding how a 
claim fits into the fabric of prior knowledge and its breadth of prior support are defined in Fig.4; for 
others see Supplementary Information. 
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 Once each claim’s correctness is estimated, we can infer the direction of the underlying genetic 
interaction using Bayes formula, derived under the assumption of conditional independence of claims and 
the independence of correctness from interaction positivity (see Methods and SI).  
 
Predicting Claim Accuracy and Interactions 
We evaluate our genetic predictions from distributions of Receiver Operator Curves (ROCs) and the area 
under those curves (AUCs) presented in Fig.2. Our model of whether a published claim links to a 
non-neutral genetic interaction, as assessed across the wide range of LINCS experiments, betrays the 
difficulty of that task (average AUC= 0.58 for GeneWays on 6.8K interactions, AUC= 0.54 for Literome 
on 25.4K interactions). The most important feature for identifying non-neutral interactions is notable, 
however: the degree of the source gene in the network of prior published knowledge, reinforcing our 
understanding of hierarchical genetic regulation. The more central the source gene, the more likely it 
controls other genes.  
 
Our model of whether a published claim correctly identifies the direction of a genetic interaction, 
conditional on the interaction not being neutral, is much more powerful (AUC=0.77 for GeneWays on 
580 interactions, AUC=0.74 for Literome on 1090 interactions), strongly influenced by both the position 
of the claim within prior knowledge and its breadth of support (Fig.3). The feature manifesting most 
predictive power is the size of the partition of published genetic effects that surround the interaction in 
question. Its positive influence suggests that the structure and direction of nearby interactions may guide 
researchers to the correct conclusion​6​. The relevance of the claim to researchers working nearby will also 
increase competition and anticipated scrutiny.  
 
The next most important class of influences are the historical depth and breadth of support. Greater ​depth 
and breadth of investigation, absolute size of the relevant research community, and the number of 
communities studying the claim are associated with empirical correctness. By contrast, empirical 
incorrectness is correlated with higher relative community size and our index tracing author, institutional 
and prior knowledge dependencies. Greater relative size indicates that the majority of scientific activity 
comes from one or a few communities and when the dependency index is high, authors, institutions and 
citations densely link published claims. Together, these findings reinforce that a lack of social and 
theoretical independence between claims should reduce our confidence in them and paint a consistent 
picture of the importance of balanced, independent investigation for scientific certainty. 
 
Using Bayesian inference, we apply these estimates to infer the direction of any given genetic interaction. 
Our out of sample predictions demonstrate substantially greater signal than random regarding the robust 
direction of a genetic interaction (AUC = 0.67 for GeneWays; AUC = 0.63 for Literome). These models 
are less predictive than our models predicting accurate research claims because of inequality in research 
attention, collectively focused on a few, popular interactions. While scientific certainty about any 
particular interaction might be satisfied with a moderate number of replications, the inequality of research 
attention and activity are more likely to furnish the 100​th​ replication of a popular claim than the 2​nd​ of an 
unpopular one, despite the drop in information this entails for science as a system.  
 
Policies to Optimize Scientific Certainty 
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 Our findings suggest scientific policies to increase collective certainty across scientific claims, here 
evaluated in the context of genetic regulatory interactions. We design one statistical experiment to 
manipulate the distribution of independent communities examining a research claim and another to 
manipulate the distribution of claims across interactions, examining their effects on the correctness of all 
scientific inferences about genetic regulatory interaction. For a research funder like the U.S. National 
Institutes of Health (NIH) to influence the number of communities studying a specific topic would require 
them simply to prefer the social, institutional and intellectual independence of each new investigation they 
fund. For the NIH to broaden the distribution of claims across interactions would require them merely to 
prefer research on new topics. We demonstrate predictively that such policies, if implemented, could 
increase correct identification of the direction of genetic regulatory interaction as measured by the AUC 
of our model.  
 
For the first statistical experiment, we divide interactions from the test sample into disjoint groups by the 
number of communities or author clusters that publish on them. For the subset of positive and negative 
interactions we (1) split the dataset into training and testing samples, (2) build the model of claim 
correctness, then using Bayesian inference (3) predict model certainty for groups of interactions having 1, 
2, 3, 4 or more communities in the test sample. The top of Fig. 4 shows that a greater number of 
communities has a profound, positive effect on the distributions of AUCs for interaction positivity. The 
more communities studying an interaction, the better we can infer correct insight from the resulting 
corpus of research. 
 
For the second statistical experiment, we artificially shift the distribution of claim numbers by sampling 
interactions according to the number of times on which each is published. Specifically, we (1) fix time  
for all interactions in the sample and consider only claims published before , (2) prepopulate the sample 
with ~20% of claims in chronological order, and then (3) repopulate the sample with claims (and thus 
interactions), year by year, until each interaction contains the complete history of observed claims. In 
Fig.4c we present two synthetic examples of claim number distribution. The claim number distribution 
can be approximated with a power law, with density function proportional to the number of interactions 
having a given number of claims about them raised to the power of some exponent, where lower values 
correspond to flatter distributions. We demonstrate that flatter claim number distributions, where 
scientific attention is spread more widely across genetic regulatory interactions, correspond to 
significantly higher AUCs predicting accurate interactions (increases of  ​for GeneWays 
and  ​for Literome).  
 
Amplifying Signal from Science 
The deluge of published scientific information available to 21st Century researchers, funders, inventors 
and developers has overwhelmed their capacity to account for all of the signals available from science in 
their efforts to innovate. Challenges associated with information overload are exacerbated in research 
about entire scientific systems, such as the regulatory interactions between all human genes as we study 
here. In such settings, knowledge is necessarily uneven and investing against our ignorance will multiply 
the value of those investments for broad scientific understanding. In this paper, we demonstrate how the 
emergence of massive digital archives, machine reading and information extraction tools, alongside 
automated experiments can help us identify and amplify the signal from science by predicting the 
7
 robustness of scientific claims. This project represents the first automated, machine-driven pipeline of 
which we are aware that reads scientific research papers, extracts information about scientific claims, 
aligns them high-throughput experiments, and provides a Bayesian update of that knowledge. Our 
approach takes into account a wide range of features including how claims fit within the web of prior 
understanding and their breadth of support. And this is precisely what individual scientific experts do 
when they critically evaluate the literature, based on deep, personal understanding of dynamics and 
reputations within their specific field, here scaled by machine to many overlapping areas of biomedicine 
beyond the scope of any single scientific reasoner. 
 
Our models predict replication based on different sets of publications, read by different algorithms, but 
yield deep consistency regarding what predicts replication and what might be altered by science policy 
makers to improve the state of scientific knowledge. These findings in the context of human genetic 
regulatory interactions, however, reveal an essential tension in the undertaking of collective scientific 
investigation. Robust genetic regulatory interactions are predicted by many investigators devoted to 
studying popular genes, central in the network of scientific claims and embedded within dense areas of 
investigation. Nevertheless, greater independence between investigators, communities, institutions, and 
prior knowledge also dramatically increase claim robustness. This leads to a paradox for science policy. 
When scientists flock together by studying the same phenomenon it increases our collective 
understanding. When they flock together in their approach and collaborations, it decreases our collective 
understanding—it increases the illusion we know more than we do. Our policy experiments suggest if 
science policy and sponsorship take this tension seriously, they could dramatically increase the robustness 
of our collective understanding and accelerate innovation. When communities, people and approaches 
focused on a given genetic regulatory interaction are more diverse, their collective findings more likely 
converge to powerful estimates derived from massive, high-throughput experiments. On the other hand, 
when scientists spread out across the space of possible claims, our overall certainty about the entire, 
interacting system of gene regulation increases. This suggests that when an important scientific process or 
component merits scientific attention, sponsoring diversity in that attention may pay dividends in robust, 
replicable understanding. On the other hand, if we seek to gain understanding about the system as a 
whole, we also increase the signal from published science by sponsoring and rewarding more work on 
under-examined areas.  
 
Our study has several natural limitations. Despite our replication of all findings with two different 
samples of research papers and claim extraction algorithms, our study nevertheless only explores claims 
about genetic interactions. Moreover, in order to evaluate those claims at scale, we only consider claims 
about regulatory interactions between pairs of genes. This excludes many other, meaningful interactions 
(e.g., methylation, phosphorylation). Both information extraction algorithms, GeneWays and Literome, 
had limitations described above, but they balanced one another in terms of precision and recall. Finally, 
the several linkages across datasets that facilitate our mapping of research claims to LINCS L1000 
experimental results necessarily excluded interactions from the literature not present in the experiment 
and vice versa. To conclude, our analysis of observational data makes it impossible for us to make strong 
causal claims about the impact of reforming scientific institutions according to the suggestive patterns we 
document. Notwithstanding these limitations, all of which would have decreased the signal we might 
expect to isolate from scientific literature, we were able to predict the likelihood of conceptual replication 
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 far above random and identify consistent patterns of focus and independence that, if enhanced, could 
substantially increase the signal from science.  
 
Methods 
Information Extraction Algorithms 
GeneWays​. This algorithm and associated database of automatically extracted claims ​43,49​ contains 
approximately 496K unique claims (aggregating so each claim is unique per publication) and 
approximately 313K unique interactions (defined as a triplet including the source gene, target gene, and 
action, and where action is a verb that takes values including ‘bind’, ‘interact’, ‘induce’, ‘associate’, 
‘regulate’, etc.) expressed in approximately 197K publications from MEDLINE. Approximately 32% of 
our claims were extracted from abstracts. We found that claims in publication could either result from 
independent original research or simply reference a finding from a cited publication. The former were 
much more likely mentioned in the abstract, and so in our research we considered only claims extracted 
from abstracts. This operation leaves us with ~172K unique publication-claims and ~130K unique 
interactions from the abstracts of approximately ~109K unique publications. 
 
A typical record in the GeneWays database has the form: ​abg​ ​prevents​ ​tert​. To simplify the 
representation of interactions, we identify all such verbs that can be interpreted as positive or negative 
directional actions. As positive, we encode: “activate”, “actuate”, “cause”, “control”, “direct”, “enhance”, 
“facilitate”, “force”, “increase”, “induce”, “lead”, “overproduce”, “promote”, “provoke”, “stimulate”, 
“transactivate”, “trigger”, “regulate”, “produce”, and “upregulate”.  As negative, we encode: “constrain”, 
“degrade”, “destroy”, “downregulate”, “hinder”, “inactivate”, “inhibit”, “interrupt”, “limit”, “reduce”, 
“repress”, “shut”, and “suppress”. After projecting the interactions to positive or negative, we are left with 
~36K unique interactions, ~68.6K unique claims from ~51K unique publications from PubMed. 
 
For each attribute, Geneways contains a flag indicating whether the claim is negative, where ~4% of 
claims are negative. According to logic, the negation of “a” increases “b” is the union of both “a” 
decreases “b” and “a” does not affect “b”, non-interactions are never recorded and so we assume a 
positive interaction is the negation of a negative interaction and visa versa. If we encounter claims with 
respect to the same interaction extracted from the same paper that negate one another, we discard them. 
We retain claims from publications that present in our version of MEDLINE from 3K journals that we 
could identify using an available copy of the Web of Science database. 
The final iteration has 23K unique interactions, 44K unique claims from 33K unique publications. 
 
Literome 
Literome ​50​ contains 144K unique interactions, 259K unique claims from 220K unique publications 
extracted from MEDLINE abstracts by means of distant supervision via Markov Logic with an estimated 
precision of 25%. We only consider claims extracted from the abstracts and note that Literome has a 
strong bias towards positive interactions (~98%). For the set of final models described in the articles, we 
exclude claims with respect to gene TP53 (Entrez id 7157) acting on CDKN1A (Entrez id 1026) because 
the 150 extracted claims on that interaction were all deemed incorrect or ambiguous as evaluated by a 
biomedical expert. 
9
  
Genetic Dataset from LINCS L1000 
We use the Library of Integrated Network-Based Cellular Signatures (LINCS) that was compiled using 
the Luminex bead technology called L1000 as the ground truth with respect to gene-gene interactions 
derived within the same context ​46​. The experimental technique of LINCS L1000 is based on tracking 
gene expression, the procedure by which information from genes chemically perturbed in the experiment 
causes the synthesis of functional gene products, such as proteins, resulting in an altered cellular 
phenotype. We use the GSE92742 Level 5 version of LINCS L1000. Level 5 dataset contains signatures 
from aggregated replicates. The experiments are performed on 77 cell lines, using different perturbation 
types, durations and dosages. Multiple experiments are performed per combination of cell line, 
perturbation type, duration and dose. The result of an experiment is a z-score, which quantifies the 
expression of a particular gene under the action of a perturbagen, relative to the baseline experiment. 
 
We aggregate the z-scores of experiments in the following manner: For a given cell line, perturbagen, 
dosage and duration we compute the mean value; then across cell lines, perturbagens, dosages and 
durations we take the maximum of the absolute value for a given interaction. The z-score is then 
transformed using normal cumulative density function (that takes values in (0, 1)). We denote this   
and call it the experimental regulatory interaction strength. 
 
For GeneWays, 40% of claims and 32% of interactions remain after merging with LINCS L1000 while 
for Literome, correspondingly 29 and 25%. After merging GeneWays and Literome onto aggregated 
LINCS L1000 data we obtain 15.5K and 50.5K claims and 6.8K and 25.4K interactions, respectively. The 
overlap between GeneWays and Literome claims merged with LINCS L1000 is 2K interactions (31% of 
all interactions iof GeneWays, 8% of all interactions of Literome) or 827 claims with correlation of the 
claim variable is .38 (representing 13% of GeneWays claims and 4% of Literome claims). The number of 
overlapping claims is greater than the number of overlapping interactions due to the majority of 
interactions being discussed in disjoint sets of publications between GeneWays and Literome. If we 
restrict the merged GeneWays-LINCS and Literome-LINCS datasets to the strongest positive and 
negative experimental regulatory interactions (intervals (0, 0.1] and [0.9. 1.0) on the interaction strength 
cdf) the overlap between GeneWays and Literome is 81 claims (34 interactions) with a correlation on the 
claim variable of .57. We conclude that GeneWays and Literome datasets are significantly different, but 
in moderate agreement where they overlap, suggesting that they are largely independent sources of 
genetic regulatory interaction claims. We note that the distribution of number of claims per interaction 
follows Zipf’s Law.  
 
The correlation between regulatory interaction strength from LINCS L1000 and mean claim value from 
the literature is negligible, but increases as we introduce a threshold for the number of publications in 
which the claim appears (see Extended Data Table 1 and Fig. 1). 
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 We define communities associated with each genetic regulatory interaction for claims made within a 
variety of fixed time intervals: the past 1, 2, 3 and all years leading up to a given year. Each claim is made 
within a unique publication, and each paper is produced in an institutional, social and knowledge context, 
reflected by the multiple affiliations, authors, and references mentioned in that paper. Denote the set of 
affiliations (or authors or references) ​V,​ publications ​U​, such that edges (​u, v)​ between members of these 
two sets form a bipartite graph, which we reduced to a weighted graph defined on the set of publications 
U​, with weights proportional to the number of common affiliations. In every such local weighted graph of 
publications defined over a given time period (i.e., 1, 2, 3, and all prior years), we identify communities 
using the information theoretically inspired Infomap algorithm​51​ and assign the number of communities, 
community size and community share for a given claim as derived features. Features deemed unimportant 
by our analysis (such as journal quality) are described in the SI and listed in Extended Data Table 2. 
 
In order to classify (1) the ​neutrality​ of a genetic regulatory interaction, (2) the ​positivity​ (or ​negativity​) of 
a regulatory interaction, and (3) the correctness of a claim, we used random forest and logistic regression 
models to enable both prediction and interpretation. While random forest allows us to reach near-maximal 
predictive performance, logistic regression enables the linear interpretation of features, rendering some 
effects positive and others negative. We choose models of optimal complexity and estimate metrics over 
the ensemble using procedures described in SI. In Fig. 3, features are presented pictorially with the 
highest Gini Importance or Mean Decrease in Impurity in the random forest model. Detailed methodology 
of feature importance calculation is located in the SI. Fig. 3 displays the Gini Importance or Mean 
Decrease in Impurity for each variable in the random forest model and associated coefficients from the 
logistic regression, plotted in decreasing importance for the Geneways random forest.  
 
We used Python and scikit-learn for testing models, large scale computations were made possible thanks 
to CloudKotta infrastructure​52​. 
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Fig.1. Joint plot of the mean value of the claim (x-axis) and mean experimental interaction strength 
(y-axis). a​, GeneWays (blue). ​b​, Literome (red). More intense hues of the blue and red (and also greater 
marker size) correspond to the interactions with 10 or more claims per interaction; for less intense hues 
(and also smaller marker size) the cutoff is absent, representing the complete distribution.  
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Fig.2. Research design and prediction results.​ We first predicted the neutrality or non-neutrality of each 
gene-gene regulatory interaction. Then, if the interaction was deemed non-neutral, we predicted whether 
each claim (of positivity or negativity) from literature was correct. Finally, using Bayesian inference, as 
illustrated here and detailed in the methods section, we estimated the positive or negativity of genetic 
regulatory interactions. The ROC curves for the prediction models are blue for GeneWays and red for 
Literome. Mean ROC curves are in bold surrounded by a 95% c.i., with fainter individual lines 
corresponding to ROC curves for 60 models; 20 for each of 3 randomly drawn sets of non-overlapping 
interactions. All models were built from interactions not present in the test set on which ROC curves were 
evaluated.  
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Fig.3. Feature visualization and estimates from claim-level prediction models.​ ​a​, illustrated 
relationship between genes engaged in regulatory interactions, the communities that research them, and 
the articles in which this research is published. Interactions cluster into partitions, researchers cluster into 
communities, and author teams publish articles within fixed periods. Together these structures are used to 
assess the position of a claim within pre-existing knowledge, the breadth of attention to a claim, and the 
independence of support for that claim. ​b​,​c​ Gini Importance or Mean Decrease in Impurity for features in 
the random forest models (left vertical scale, bold colors), and coefficients from the logistic regression 
models (right vertical scale, fainter colors) for GeneWays (​b​) and Literome (​c​). Vertical bars represent 
95% c.i. for the mean value of the estimate. See Supplement for details about how specific 
operationalizations of each of these variables were selected as model features.   
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Fig.4.​ ​Science policy experiments revealing the relationship between community independence, 
collective attention, and certainty about genetic regulatory interactions.​ ​a​, relationship between the 
number of communities studying a particular genetic regulatory interaction and the average AUC of 
out-of-sample predictions for positive interactions. ​b-c​, distributions of the average AUC curves for 
GeneWays and Literome for interactions with 1, 2-3 and greater than 4 communities. ​e-f​, relationship 
between the shape of the distribution of number of claims per interaction on the AUC of out-of-sample 
predictions for positive interactions.  represents the slope of the claim number per interaction 
distribution for GeneWays (​e​) and Literome (​f​). ​g​, two synthetic examples of claim number distributions, 
where these distributions can be approximated with power laws, proportional to the number of claims 
about an interaction raised to the power of some exponent ​, such that lower values correspond to flatter 
distributions. In flatter claim number distributions, scientific attention spreads more widely across genetic 
regulatory interactions, which corresponds to significantly higher certainties (AUCs) of accurate 
interactions.  
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Supplementary Information
1 Definitions
Following are definitions to enable precise articulation of all calculations and procedures.
gs - source gene or gene product involved in a genetic regulatory interaction.
gt - target gene or gene product involved in a genetic regulatory interaction.
α - index for each genetic regulatory interaction (gs, gt).
pˆiα - interaction strength estimated from LINCS L1000, averaged over experiments of the same
type, maximized over cell type, duration, and dosage.
cαi - claim with respect to interaction α from publication i.
yαi - correctness of published claim, defined with respect to interaction α mentioned in publication
i. We operationalize it here as the difference between the published claim and results from the
LINCS L1000 experiment: yαi = 1− |cαi − piα+|.
µˆα - mean claim value, where the sum runs over all claims with respect to interaction α:
22
µˆα =
1
n
nα∑
i=1
cαi
piα0 - indicator variable for interaction α: equal to 1 if α is neutral, 0 if positive or negative.
piα+ - indicator variable defined on the subset of positive and negative interactions: equal to 1 if α
is positive, 0 if negative.
2 GeneWays and Literome alignment with LINCS L1000
Table 1 and Fig. 1.
3 Experimental setup
Interaction/claim partition We partition gene - gene (or gene product) regulatory interactions
from LINCS L1000 into three classes corresponding to negative, neutral and positive interactions.
We do so by introducing thresholds θ− and θ+ that separate correspondingly negative from neutral
and neutral from positive regulatory interactions in the space the experimental findings (pˆiα). This
section explains our method for determination of θ− and θ+.
Formally we partition negative, neutral and positive interactions, respectively: A− = {α|pˆiα <
θ−},A0 = {α|θ− ≤ piα < 1−θ+},A+ = {α|pˆiα ≥ 1−θ+}, with 0 < θ− < 1 and 0 < θ+ < 1−θ−.
We define an indicator function piα0 onA, equal to 1 if interaction α is neutral (A0) and 0 oth-
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erwise. Defined in this way, piα0 is the target variable for the model predicting neutral interactions.
On A−
⋃A+ we define an indicator function piα+, which takes value 1 if interaction α is
positive (A+) and 0 otherwise (negative). Defined in this way, piα+ is the target variable for our
model predicting positive interactions.
For claims attributed to interactions A−
⋃A+ we define claim correctness as the difference
between the claim and the experimental results:
yαi = 1− |cαi − piα+|
Claim correctness is 1 when the claim is correct (both the claim and the interaction are
positive, or when both are negative) and 0 otherwise.
In the following we derive features at two broad levels of analysis: 1) features attributed to
each genetic regulatory interaction (i.e., fα), such as the degree or the partition size; and 2) features
attributed to claims published in each article about each interaction (i.e., fαi ).
We use interaction level features (fα) in predictive models of the neutrality of a genetic
regulatory interaction (piα0 ) and its positivity (pi
α
+). We correspondingly use features associated
with published claims (fαi ) in predictive models of claim correctness. Because claim correctness
is defined for positive and negative interactions, we can use our probabilistic estimates of claim
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correctness to assist with the prediction of correct interactions (piα+).
LINCS L1000 thresholds In this section we describe our data-driven approach to defining thresh-
olds that partition interactions into neutral (A0), negative (A−) and positive (A+).
The threshold could be set to a constant value in an ad hoc manner: θ− = θ+ = ε, e.g.
ε = 0.15. Alternatively, it could be set θ− and θ+ by a fixed percentile level:
θ− : ε =
θ−∫
0
ρ(piα)dpiα, θ+ : ε =
1∫
1−θ+
ρ(piα)dpiα
While both of these definitions of ε are simple, they depend on the choice of an arbitrary
constant. We propose and implement an approach that takes into account how these interactions
are presented in the scientific literature.
We denote the set of all claims C. We note that a partition of A induces a partition of C
into C+, C− and C0, for example C+ = {cαi |α ∈ A+}. We propose to define threshold θ+ so that
it maximizes the distance between C+ and C0, and, correspondingly, θ− to maximize the distance
between C− and C0.
We assume that claims for each interaction α are generated from a binomial distribution with
parameter µα, which is generated from a beta distribution with class-wide parameters a, b. Beta
distributions for each class can be estimated following the Bayesian update procedure:
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gx(µ) = Beta
(
a0 +
∑
α∈Cx
nα∑
i=1
yαi , b0 +
∑
α∈Cx
(
nα −
nα∑
i=1
yαi
))
We then define the distance between two disjoint subsets of C as the Wasserstein distance
between two probability measures, in our case - beta posteriors. We note that the Kullback-Leibler
(KL) divergence would be less suitable due to Beta function having very localized support for large
values of a and b.
Distribution gx(µ) are probability measures defined on a metric space [0, 1] with metric d,
Euclidean L2 distance in our case. The distance between C+ and C0 is computed as
W (g+, g0, θ−, θ+) = inf
γ∈Γ(g+,g0)
∫
d(x, y)dγ(x, y),
where Γ(g+, g0) denotes a collection of all measures with marginals g+ and g0. Note that θ−
and θ+ define g+, g0 and g−.
Increasing thresholds θ+ and θ− corresponds to redistributing claims from A0 to A+ and A0
to A−, respectively. Due to the discrete nature of our datasets, such redistribution occurs discon-
tinuously and so we do not expect distances W (g+, g0) and W (g−, g0) to depend continuously on
thresholds.
We postulate that we want to maximize relative discontinuity δR in the distance rather than
the distance W itself:
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δRf(x0) = lim
x→x+0
f(x)− f(x0)
f(x)
,
δLf(x0) = lim
x→x−0
f(x)− f(x0)
f(x)
,
where δRf(x0) is the relative discontinuity from the right (the limit x→ x+0 is understood as
sequence of xn > x0), and δL(x0) - from the left (xn < x0). Finally we define the optimal values
θ∗− and θ
∗
− as:
θ∗− = arg min
θ−
δLW (g−, g0, θ−, θ+)
θ∗+ = arg min
θ+
δRW (g+, g0, θ−, θ+)
On the one hand, we would like to maximize relative discontinuity. On the other hand, we
would like to have a relatively large number of claims in C+ and C− in order to use statistical
methods. In Fig. 3 we show plots of W (g−, g0, θ−) for a fixed θ+ and W (g+, g0, θ+) for a fixed θ−
for both the GeneWays and Literome datasets.
In Fig. 4 we show plots of distances W (g−, g0, θ−, θ+) and W (g+, g0, θ−, θ+) as functions
of θ− and θ+ for GeneWays. As expected, the dependence on θ+ for W (g−, g0, θ−, θ+) and θ−
for W (g+, g0, θ−, θ+) are weak. The corresponding plots for Literome are similar, although less
pronounced. Armed with this observation we simplify our optimization problem:
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θ∗−, θ
∗
+ = arg min
θ−,θ+
δLW (g−, g0, θ−, θ+)δRW (g+, g0, θ−, θ+)
and obtain optimal values of θ− and θ+ to obtain (0.305, 0.218) for GeneWays and (0.256,
0.157) for Literome.
As a result of this procedure, we select positive and negative interactions: 2476 claims about
580 interactions for GeneWays and 2720 claims about 1090 interactions for Literome. Note that
the main results reported in the paper are qualitatively the same if we take fixed thresholds for class
definition.
Models We build our models of interaction classification in a hierarchical way. Our first model
answers the question whether interaction α is neutral: P (piα0 = 1|fα).
Conditional on interaction α being non-neutral we can estimate whether it is positive: P (piα+ =
1|fα, piα0 = 0). The full probability that interaction α is positive is
P (piα+ = 1|fα) = P (piα+|fα, piα0 = 0)P (piα0 = 0|fα)
In summary, whenever we have access to scientific claims from the literature and we can
model their correctness based on independent evidence, the estimate of interaction positivity α
can be augmented via Bayes formula in the following way. We can estimate the positivity of
an interaction (piα+) as a function of claims (c
α
i ) and features (f
α
i ) by using our estimate of claim
correctness (yαi ), assuming conditional independence between claims.
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P (piα+|{cαi , fαi }) ∝ P ({cαi , fαi }|piα+)P (piα+) ∝
∏
i
P (cαi , f
α
i |piα+)P (piα+)
∝
∏
i
P (piα+)
∑
yαi
P (cαi |yαi piα+)P (yαi |fαi )
Alternatively we use interaction level features for the model of positive interactions: P (piα+ =
1|fα).
We note that some of the features detailed in the following section do not assume the condi-
tional independence of each claim. We minimize the size of these dependencies and their potential
to distort our estimates, as we describe in detail below in the section on sampling, by separating
genetic regulatory interactions across training and testing samples, such that no dependencies fit
within the training data can artificially inflate our predictions in the testing data.
4 Features
Below we define features used in models of interaction neutrality, positivity and claim cor-
rectness. In order to predict interaction neutrality, we derive features from the publicly available
knowledge network of published claims. All features are defined using data available before, or in
special cases contemporaneous with the prediction in question.
Claim features are defined at multiple levels: 1) at the level of genetic regulatory interactions
indexed by α (e.g., the centrality of the interaction in the network of other published interactions);
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2) at the level of the claim ‘batch‘, defined as the set of claims with respect to the same interaction
(α) within a predefined time interval (at time t and window-size w), indexed by α, t, w (e.g., num-
ber of claims made with respect to an interaction before a given year); and finally 3) at level of the
publication (i) indexed by α, i, where i indexes all publications pertaining to interaction α (e.g.,
citation impact of the journal or status rank of the university affiliations held by authors when the
published the article).
Interaction-level features
Mean claim percentile
Mean claim value (µˆα) is the average value over published Boolean (positive or negative)
claims cαi pertaining to interaction α. We define mean claim percentile (MCP) pα = P (x < µˆ
α)
and absolute value of the median mean claim percentile (AMMCP) δpα = |pα − 0.5|. Calculation
of the AMMCP is motivated by high skewness in the distribution of mean claim values. We expect
mean claim percentile to be predictive in our model of interaction positivity, and absolute median
of the mean claim percentile to be predictive in our model of interaction neutrality.
Gene degree
We consider the directed network of genes, where edges are ordered pairs of source/target
genes or gene products (gs, gt), corresponding to the regulatory action of gs on gt (interaction α)
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mentioned in a publication. The incoming degree of a gene is the number of all source gene (gs)
for which the focal gene is a target (gt). By analogy, the outgoing degree of a gene is the number
of all target genes (gt) for which the focal gene is a source (gs).
Interaction partition
We combine GeneWays and Literome datasets and assign weights to the edges according
to the number of claims made before time t. By convention, we normalize the GeneWays and
Literome data so that a publication contains only one mention of any particular interaction. We
then use the InfoMap and Multilabel community detection algorithms 7 to partition the interactions
into clusters using the igraph python package8. We identify dynamic community structure as a
function of time with no loss of memory. For example, the interaction partition for interaction α
in 1970 is defined for all interactions published prior to and including 1970.
We define the effective size of each interaction partition as the geometric mean Sα =
√
SgsSgt ,
of Sgs and Sgt , the sizes of communities containing gs and gt correspondingly and call this quan-
tity Interaction Partition Size (IPS). An interaction is an edge between genes or gene products, so
the two genes can either belong to the same or different partitioned communities. We call such a
flag, taking value True in former case (same partition) and False otherwise, Interaction Partition
Position (IPP).
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Interaction history length
We define the interaction of history length (∆ years) as the difference in years between the
last and the first published claims on this genetic regulatory interaction.
Batch level features
Claim Popularity & Claim Density
Let Cα be the partition of all claims by interaction and C(t) the partition of claims by year
of publication. Then the number of claims with respect to interaction α at time t is να(t) =
|Cα ∩ C(t)|.
We define Claim Popularity (CP) in time window w as the number of claims published in
time interval (t − w, t). For the strict case in which we do not consider claims published in
the same year, CPα(t, w) =
∑
t−w<t′<t
να(t
′). We also consider the non-strict, right continuous
case in time interval (t − w, t] where we additionally consider claims published in the same year,
CPαrc(t, w) =
∑
t−w<t′≤t
να(t
′).
We define Claim Density (CD) as the number of published claims about interaction α within
time window w: ρ(t) = CPα(t, w)/(t− t0 + 1) and ρrc(t) = CPαrc(t, w)/(t− t0 + 1).
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Claim density uniformity
We also consider Claim Density Uniformity (FLAT): for a given interaction we consider the
number density of claims in time window (t0 − w, t) and (t0 − w, t] and compare it to a uniform
distribution using the Kolmogorov-Smirnov test and use the KS statistic as a feature. A low KS
statistic corresponds to a “flat” distribution of claims in time.
Journal quality
To measure journal quality (JQ) we use the article influence metric 9, which draws on a
recursively weighted centrality of each article in terms of article citations, computing using the
eigenvector of the article citation matrix. We apply this to our version of the Web of Science
database (containing 57M unique publications) to derive the ranking of journals from 1990 through
2014 (only 4% of GeneWays and 4% of Literome claims, intersected with LINCS L1000, are
dated before 1990). We use the prior 5 year window of journals citing journals to derive the article
influence metric (ai), computed for each journal at each time point. This calculation of journal
quality drew on capabilities of the Cloud Kotta platform 6.
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Affiliation rank
In order to evaluate the affiliation rank (AR) we use the top 100 QS World University Rank-
ings of biological sciences from 2011. From the non-zero intersection of both GeneWays and
Literome claims with LINCS L1000 approximately 21% have the affiliation in the top 100 Univer-
sity Ranking of biological sciences, whereas the fraction of claims for which no affiliation could
be identified from the data available is only 3% for GeneWays and 4% for Literome.
Citation count
From the Web of Science we obtain current citation counts for 97% of the publications of
interest from GeneWays and Literome datasets. The mean citation count for GeneWays dataset is
approximately 57, while for Literome it is 62. Along with the raw citation count, we also fit the
citation history for each publication to a lognormal distribution:
P (Ct) ∝ 1
tσ
√
2pi
e−
(ln t−µ)2
2σ
and use parameters of that log-normal distribution µ and σ as features. The fit allows us to
estimate the projected total citation count A, which we also consider as a feature.
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Herfindahl index of affiliations and authors
We calculate the Herfindahl index of affiliations and authors to capture the inequality of at-
tention and associated dependence between articles published by the same authors at the same
institutions. We disambiguate affiliations using the hierarchical distance technique 5, which takes
advantage of the trace of the ordered matrix of institution terms (e.g., to distinguish between Wash-
ington University and the University of Washington). We then compute the relative weight for each
affiliation fjα(t) and interaction α at time t as the sum over contribution for all preceding time.
Let Ai be the set of affiliated institutions listed in publication i. We use the simplifying
assumption that each publication i carries weight 1, which is divided equally between all the unique
identifiable affiliations of authors. This is useful because the Web of Science did not explicitly link
affiliations to authors for 20th Century publication data. We define the contribution of a publication
to the weight of an affiliation as:
wijα(t) =

1
|Ai(t)| , j ∈ Ai(t)
0, j 6∈ Ai(t)
At a given time the weight of a affiliated institution j in the history of an interaction α is the
sum over the weights from relevant publicationswjα(t) =
∑
t′<t, i:j∈Ai
wijα(t
′). We define normalized
weight (NW) fjα(t) of affiliation j:
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fjα(t) =
wjα(t)∑
j wjα(t)
,
and normalized Herfindahl index (NHI) nhiα(t) as
hiα(t) =
∑
f 2jα(t); nhiα(t) =
hiα(t)− 1/Kα(t)
1− 1/Kα(t) ,
where Kα(t) is the number of affiliations associated with interaction α up to time t:
Kα(t) =
∣∣∣∣∣ ⋂
t′<t, i∈Bα
Ai(t
′)
∣∣∣∣∣ .
In a comparable way, we derive relative weights and the normalized Herfindahl index for
authors as well. These indices capture how much a few institutions and authors are responsible for
research attention to a claim. If the Herfindahl indices are low, then attention to the claim is spread
across many institutions and authors.
In the correlation plots (Fig. 7) normalized weights and normalized Hefindahl index are
denoted NW affs and NHI affs and correspondingly NW authors and NHI authors for affiliated
institutions and authors: NW is defined at the claim level, while NHI - at the batch level.
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Dependency index
We define two new network measures to directly measure their indirect dependency upon one
another. These naturally relate to, but expand on the Herfindahl index measures described above.
Our dependency indices are measured at the level of an individual claim, and also at the level of a
batch of claims. Our claim-level dependency index measures how well each node from one com-
ponent of the network connects to others of the same type through nodes in the other component.
If genetic regulatory interaction claims have high dependency on one another through the same
shared authors, affiliated institutions, or shared references, then they are not independent from one
another. Our batch-level dependency index measures how one entire component – one type of
nodes – in a bipartite graph is connected through the other. As with the claim-level dependency-
index, but at the collective level of all claims within a batch, more dependency between claims
means less independence.
Consider a bipartite graph G = (U, V,E), where the only possible edges connect nodes from
set U to set V . In our case, U represents the set of publications, and V - the set of affiliations,
authors or referenced articles. We characterize the connectedness of a bipartite graphG by a single
number, not by the relative number of edges |E||U ||V | as a metric, but rather to encode the shape of
the degree distribution of U with a single number.
We propose to use the relative λth moment in f -percentile as a metric describing how well
U is supported on V and call it the batch-level dependency index. Let di be the degree of vertex
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in V . There are |V | such vertices. We denote the sum over the f percentile of greatest degrees,
such that di > kf , where kf is found from the equation
∑
i 1{di>k}
|V | = f , where 1 is the indicator
function, by a prime (′). And so the λth moment in f -percentile is
〈dλ〉f =
∑′ dλi
f |V |
To normalize the degree moment we define the fractional dependency index as the ratio of
〈dλ〉f to the maximum degree to the power λ: dλmax = |U |λ.
σf,λ(G) =
〈dλ〉f
|U |λ
For example, consider three research claims published across three separate articles: c1 writ-
ten by Alice and Bob, c2 by Alice and John and p3 by Alice, John and Mary. In this case authors
play the role of the V set, with Alice, John, Mary and Bob having correspondingly degrees 3, 2, 1,
1. If f is set to 0.5 and λ = 1, 〈d〉0.5 = 2+32 . With |U | = 3, σ0.5,1 = 0.83.
We define the dependency index for u ∈ U to all other vertices in U through shared connec-
tions to vertices in V in the following manner: let dv be the degree of vertex v in V .
affG(u) =
∑
v:∃(u,v)
(dv − 1)
d(u)(|U | − 1)
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It follows from our definitions that 0 ≤ σf,λ(G) ≤ 1 and 0 ≤ affG(u) ≤ 1.
For each interaction α and time t at which the claims on interaction αwere made, we consider
a subset of publications made during time interval (t − k, t], which forms U , then set V consists
of the corresponding affiliations, authors or references. We also consider the case of unbounded
past-looking windows (−∞, t].
For the support metric we use λ = 2, f = 0.2 for references and f = 0.5 for affiliations and
authors, as there are many more distinct references than affiliations or authors.
In the correlation plot (Figs. 8) dependency indices are denoted as CDEP and BDEP respec-
tively. As mentioned above, CDEP is defined at the claim level, while BDEP is defined at the batch
level.
Claim community number (CCN), community size (CSI) and community share (CSA)
The number of claim communities captures the separated, largely independent research ef-
forts, defined across authors, institutions, and motivating referenced articles. Community size
measures the number of researchers within the connected community surrounding a given claim,
and community share the proportion of all claims within the batch are represented by those within
that community. See
As in the case of our dependency indices, we consider a bipartite graph where set U consists
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of publications and set V affiliations, authors or references. We identify communities using the
Infomap method in the projection of G(U, V,E) on U with weights of edges defined as
wab =
|Nei(a)⋂Nei(b)|
|Nei(a)⋃Nei(b)| , Nei(a) = {v ∈ V |(a, v) ∈ E},
whereNei(a) is the set of neighbors of a. In Figs.5 and 6 we present the correlations between
the interaction level features and interaction neutrality piα0 and interaction positivity pi
α
+ respectively.
In Figs.7 8 we present the correlations of batch and correspondingly claim level features with claim
correctness yαi .
5 Experimental setup
Sampling Here we detail our sampling techniques and discuss the use and role of predictive mod-
els in our analysis. We chose logistic regression and random forest models for our prediction tasks.
Logistic regression enables interpretability, while random forests brings us closer to maximal pre-
dictive performance.
In order to evaluate out-of-sample predictions and estimate the distributions of metrics of
interest (such as area under the curve (AUC) for receiver-operator characteristic (ROC)) for in-
teraction level models, we generate 20 3-fold random samples by genetic regulatory interaction.
This amounts to having 60 model-level datapoints, which form the basis of each point or line of
performance in Fig. 2 and 4.
For models of claim correctness and interaction positivity (which claim correctness), we need
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to alter the sampling procedure in order to avoid an artificial inflation of performance. Claims are
conditional on interactions, and so if they are sampled randomly, the same interaction may have
claims in both test and the training samples, falsely boosting the appearance of performance. We
employ the following technique: we array interactions according to their popularity distribution
function, which we model with Zipf’s law (a discrete power law distribution). We then randomly
sample claims associated with interactions from the training sample and attribute the remainder to
the test sample. In this way, in the evaluation of the positivity model we are not testing it on claims
that rely on interactions seen during the training phase.
Model selection For random forest models, we vary the depth of the trees from which they ensem-
ble, the minimum leaf size and the number of estimators to find a combination that optimizes the
AUC of the test set. We find that unlike the AUC on the training set, which increases with model
complexity, the AUC of the test remains approximately flat as a function of model parameters. For
all experiments we fix the tree depth to 2, number of estimators to 100 and the minimum number
of samples in the leaf to 2% of the sample size. For logistic regression model we use an L1 penalty
to introduce sparsity and vary the penalty coefficient until there are exactly 5 non-zero coefficients.
For all AUC plots, the error bands denote 95 percent confidence region for the mean AUC Figs.
[10-12].
We conclude that we are generally in regime of high variance and therefore it is desirable to
use models of low complexity, and apply such techniques as bagging.
While to answer the question if an interaction is positive and not negative we focus mainly
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on the Bayesian approach utilizing claim correctness, we also evaluated a model based on purely
interaction level features, derived as for the model claim neutrality from the network of sociological
claims. The performance of this model is comparable to the one obtained using Bayes law, as can
be seen in Fig. 11. The importances for this model are shown in 14
Evaluation of feature importance In evaluation of interaction neutrality and positivity models,
we calculate feature importances1 of the random forest model and the coefficients of the logistic
regression as simple averages over samples
For the model of claim correctness, we aggregate features into feature families as presented
in Table 2. For each sample and family we sum the importances for the random forest models and
the coefficients for the logistic regressions and then compute the mean over samples.
We use the same procedure for random forest and logistic regression to describe the robust
importance of feature families. In the case of logistic regression, it also sheds light on the sign of
the effect.
6 Policies
Based on our analyses, the striking importance of community number in predicting robust
findings (Fig. 3) and the uneven distribution of research attention (Fig. 1), we consider two policies
1 We use impurity-based feature importances: the total reduction of the criterion brought by that feature, also
known as the Gini importance.
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that could increase the overall identification of the sign of interaction as measured by the AUC of
the model evaluated on our test set.
In the first virtual experiment, we divide interactions in the test set by the number of batch
communities estimated according to authorship. In the second experiment, we evaluate the AUC
on hypothetical, historical sub-samples, for which we artificially vary the number of claims to alter
to the claim distribution across all genetic regulatory interactions.
Examples of such subsamples are presented in Fig. 15 and 16.
For the second experiment we estimate AUCs and information gain (IG), defined
IG = ent(p(0))− 1
k
α=k∑
α=1
ent(pα)
. Here pα is the estimated distribution of interaction α and ent(pα) = −∑ pαi log pαi and p0 is a
non-informative Bernoulli with parameter ν = 0.5 We note that flatter distributions corresponds to
higher AUCs and greater average information gains in a statistically significant way, cf. Figs. 15
and 16.
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GeneWays Literome
nc 0 2 4 6 8 0 2 4 6 8
size 6825 921 466 294 215 25411 3080 1413 868 613
ρ 0.048 0.107 0.169 0.17 0.21 -0.004 0.032 0.059 0.061 0.068
mean 0.749 0.78 0.79 0.804 0.8 0.978 0.98 0.98 0.981 0.98
Table 1: Sizes of datasets, based on the threshold number of claims required per genetic
regulatory interaction (nc); the correlation (ρ) between the distribution of agreement over
interaction positivity from literature (µˆα) and derived from the LINCS L1000 experimental
z-scores (piα); and mean interaction positivity (µˆα) from literature.
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feature family number of features description
MCP 1 mean claim percentile
AMMCP 1 absolute median mean claim percentile
affiliation count 1 number of affiliations per publication
author count 1 number of authors per publication
CDEP 12 claim-level dependency indices for affiliations,
authors and references times 4 windows sizes
JQ 1 journal quality
AR 1 affiliation ranking
popularity (CP), density (CD) 16 popularity and claim densities, defined by strict
and non strict right inequality, times 4 window
sizes
citations 8 citation metrics: number of citations in the first
3 years, 3 parameters of the lognormal fit and
their logarithms, flat whether the lognormal fit
was successful
degrees 4 source degree in/out, target degree in/out
∆ year 1 time difference between the first and the last
available publications on interaction in years
FLAT 8 uniformity of popularity, defined by strict and
non strict right inequality, times 4 window sizes
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feature family number of features description
IPS 18 interaction partition size 1
IPP 6 interaction partition position
NW 2 normalized weight for authors and affiliations
NHI 2 normalized Herfindal index for authors and affil-
iations
CCN 12 claim community number, 4 windows, size for
authors, affiliations references
CSI 12 community size, 4 windows, size for authors, af-
filiations references
CSA 12 community share, 4 windows, size for authors,
affiliations references
CDEP 12 claim-level dependency index, 4 windows, size
for authors, affiliations references
BDEP 12 batch-level dependency index, 4 windows, size
for authors, affiliations references
time 2 year off and year off2, time in years between the
current publication and the first publication on a
given interaction
Table 2: Feature families.
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Figure 1: Correlation of mean claim value µα and interaction strength pˆiα from LINCS L1000 as a
function of threshold on minimum claim sequence length per interaction for GeneWays (left) and
Literome (right).
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Figure 2: Claim number density for GeneWays (top panel) and Literome (bottom panel) all inter-
action (left) and selected positive/negative interactions.
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Figure 3: Distance between the classes of neutral C0 and negative C− interactions W (g−, g0, θ−)
(solid green line), number of of claims on the negative class C− n−(θ−) (dotted green line),
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Figure 5: Pearson correlation heat map vector between piα0 and interaction level features for Ge-
neWays (top panel) and Literome (bottom panel).
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Figure 6: Pearson correlation heat map vector between piα+ and interaction level features for Ge-
neWays (top panel) and Literome (bottom panel).
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Figure 7: Pearson correlation heat map vector between claim correctness yαi and batch level fea-
tures for GeneWays (top panel) and Literome (bottom panel).
0.3 0.2 0.1 0.0 0.1 0.2 0.3
CD
EP
_af
filia
tio
ns
CD
EP
_au
tho
rs
CD
EP
_pa
st
CD
EP
2_a
ffil
iat
ion
s
CD
EP
2_a
uth
ors
CD
EP
2_p
ast JQ AR
cou
nt_
aff
ilia
tio
ns
cou
nt_
au
tho
rs
pre
_af
fs
pre
_au
tho
rs
CS
I_a
fau
pa
CS
I_a
ffil
iat
ion
s
CS
I_a
uth
ors
CS
I_p
ast
CS
I2_
afa
up
a
CS
I2_
afa
up
afu
CS
I2_
aff
ilia
tio
ns
CS
I2_
au
tho
rs
CS
I2_
pa
st
CS
A_a
fau
pa
CS
A_a
fau
pa
fu
CS
A_a
ffil
iat
ion
s
CS
A_a
uth
ors
CS
A_p
ast
CS
A2
_af
au
pa
CS
A2
_af
au
pa
fu
CS
A2
_af
filia
tio
ns
CS
A2
_au
tho
rs
CS
A2
_pa
st A
A_l
og
A_l
og
_si
gm
a
cou
nt_
cit
e err mu
sig
ma
gw
lit
Figure 8: Pearson correlation heat map vector between claim correctness yαi and claim level fea-
tures for GeneWays (top panel) and Literome (bottom panel).
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Figure 10: Neutral interactions model selection. GeneWays (top row), Literome (bottom row).
Left: the distribution of ROC AUC as a function of depth of random forest. Center: the distribution
of ROC AUC as a function of minimum number of samples in a decision tree leaf. Right: the
distribution of ROC AUC as a function of the number of trees in a random forest.
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Figure 11: Positive interactions model selection. GeneWays (top row), Literome (bottom row).
Left: the distribution of ROC AUC as a function of depth of random forest. Center: the distribution
of ROC AUC as a function of minimum number of samples in a decision tree leaf. Right: the
distribution of ROC AUC as a function of the number of trees in a random forest.
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Figure 12: Claims model selection. GeneWays (top row), Literome (bottom row). Left: the
distribution of ROC AUC as a function of depth of random forest. Center: the distribution of ROC
AUC as a function of minimum number of samples in a decision tree leaf. Right: the distribution
of ROC AUC as a function of the number of trees in a random forest.
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Figure 13: Family importances of random forest model (left, darker shade) and logistic regres-
sion coefficients (right, lighter shade) for the model of classification of neutral interactions for
GeneWays and Literome. Vertical centered lines show 95% confidence level on the mean of the
corresponding importance/coefficient.
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Figure 14: Family importances of random forest model (left, darker shade) and logistic regres-
sion coefficients (right, lighter shade) for the model of classification of positive interactions for
GeneWays and Literome. Vertical centered lines show 95% confidence level on the mean of the
corresponding importance/coefficient.
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Figure 15: Typical examples of distributions of claim number ρ(nα) per interaction for test sub-
samples. Left: GeneWays, right: Literome.
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Figure 16: Information gain as a function of the slope of length distribution β for the length policy.
Solid lines correspond to binned averages and the shaded region to the binned region within one
standard deviation. Left: GeneWays, Right: Literome.
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